Ellicott City, MD, United States of America

S Mitchell Harman

This inventor holds 5 USPTO granted patents, plus 1 CIPO patent. Top assignees: Endocon, Inc., Engineering Development Associates, Ltd.. Active years: 1987-1992.

IDiyas Innovation Intelligence. (2026). Inventor Profile: S Mitchell Harman. Retrieved from https://idiyas.com/inventor/s-mitchell-harman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 1.7

ph-index = 5

Forward Citations = 638(Granted Patents)


Location History:

  • Ellicot City, MD (US) (1989 - 1991)
  • Ellicott City, MD (US) (1987 - 1992)

Company Filing History:


Years Active: 1987-1992

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: S Mitchell Harman: Innovator in Bioerodible Peptide Delivery Systems

Introduction

S Mitchell Harman is a notable inventor based in Ellicott City, MD (US). He has made significant contributions to the field of bioerodible drug delivery systems, holding a total of 5 patents. His work focuses on innovative methods for administering peptides in a controlled manner.

Latest Patents

Harman's latest patents include the "Manufacture of partially fused peptide pellet." This invention describes a bioerodible pellet capable of administering an even and continuous dose of a peptide over a period of up to a year when subcutaneously implanted. The bioerodible implant is a partially-fused pellet, which has a peptide drug homogeneously bound in a matrix of a melted and recrystallized, nonpolymer carrier. Preferably, the nonpolymer carrier is a steroid, particularly cholesterol or a cholesterol derivative. In one embodiment, the peptide drug is growth hormone-releasing hormone. A method for making the bioerodible pellet is also provided.

Career Highlights

Throughout his career, S Mitchell Harman has worked with various companies, including Endocon, Inc. and Engineering Development Associates, Ltd. His experience in these organizations has contributed to his expertise in the development of innovative drug delivery systems.

Collaborations

Harman has collaborated with notable professionals in his field, including Robert J Leonard. These partnerships have enhanced his research and development efforts, leading to advancements in peptide delivery technologies.

Conclusion

S Mitchell Harman's contributions to the field of bioerodible drug delivery systems highlight his innovative spirit and dedication to improving medical treatments. His patents and collaborations reflect a commitment to advancing healthcare through technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…